AMSF — what changed in the latest 10-Q
A section-by-section comparison of AMSF's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-10-30 vs the prior 10-Q · 2026-07-23
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +6 | −7 | ~26 | 14 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 18 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 18 |
| Other information | Text added/removed | 0 | 0 | ~1 | 18 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings, Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-10-30
Income Tax Expense. Income tax expense for the three months ended September 30, 2026 was $1.8 million, compared to $3.7 million for the same period in 2025. The effective tax rate for the Company for the quarter ended September 30, 2026 was 20.0% compared to 21.0% in the third quarter of 2025. The d…
Net cash provided by investing activities was $9.5 million for the nine months ended September 30, 2026, compared to net cash provided by investment activities of $37.7 million for the same period in 2025. Cash provided by sales and maturities of investments totaled $95.5 million for the nine months…
Net cash used in financing activities in the nine months ended September 30, 2026 was $33.7 million, compared to net cash used in financing activities of $27.4 million for the same period in 2025. In the nine months ended September 30, 2026, $23.0 million of cash was used for dividends paid to share…
Effective June 30, 2026, the Company entered into an agreement to commute its 2024 reinsurance treaty, which provided $10.0 million in coverage for each loss occurrence in excess of $10.0 million. As no losses were incurred subject to the treaty, the Company exercised its option to commute and recei…
The carrying value of our investment portfolio, including cash and cash equivalents, totaled $753.3 million at September 30, 2026, compared to $796.8 million at December 31, 2025, a decrease of 5.5%. Purchases of fixed maturity securities are classified as available-for-sale or held-to-maturity at t…
Text removed vs the prior filing · source: 10-Q · 2026-07-23
Income Tax Expense. Income tax expense for the three months ended June 30, 2026 was $3.7 million, compared to $3.5 million for the same period in 2025. The effective tax rate for the quarters ended June 30, 2026 and 2025 was 20.1%.
Net cash provided by investing activities was $30.3 million for the six months ended June 30, 2026, compared to net cash provided by investment activities of $33.1 million for the same period in 2025. Cash provided by sales and maturities of investments totaled $73.0 million for the six months ended…
million in cash was used to purchase investments in the six months ended June 30, 2026, compared to $20.2 million in purchases for the same period in 2025. There were immaterial purchases of property and equipment in the six months ended June 30, 2026, compared to $1.1 million for the same period in…
Net cash used in financing activities in the six months ended June 30, 2026 was $25.8 million, compared to net cash used in financing activities of $18.4 million for the same period in 2025. In the six months ended June 30, 2026, $15.4 million of cash was used for dividends paid to shareholders comp…
Effective June 30, 2026, the Company entered into an agreement to commute its 2024 reinsurance treaty, which provided $10 million in coverage for each loss occurrence in excess of $10 million. As no losses were incurred subject to the treaty, the Company exercised its option to commute and receive t…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice